Collectively, these data demonstrate that Rnf168 is required for in vitro and in vivo CSR, and its inactivation in mutant mice leads to immunodeficiency, which parallels the symptoms of the RIDDLE syndrome. This evidence concerns the gene RNF168 and RIDDLE syndrome.